newsBreast Reconstructionacellular dermal matrix
Does Industry Influence Persist? Financial Conflicts and ADM Outcomes After the 2021 FDA Safety Alert: A Case Report Analysis
By MedXY|Aug 20, 2026
This report examines the ongoing association between industry payments and positive outcomes reported in acellular dermal matrix (ADM) studies following the 2021 FDA safety alert.